Semaphorin 3A mitigates lipopolysaccharide-induced chondrocyte inflammation, apoptosis and extracellular matrix degradation by binding to Neuropilin-1

References

• Ordeberg G. Characterization of joint pain in human OA. Novartis Found Symp. 2004;260:105–115. discussion 115-121, 277-109.
   PubMedGoogle Scholar
• Shelton LR. A closer look at osteoarthritis. Nurse Pract. 2013;38(7):30–36. quiz 36-37.
   PubMedGoogle Scholar
• Ye ZZ, Zhang ZY, Li ZG, et al. Toward wiping out osteoarthritis in China: research highlights. Chin Med J (Engl). 2020;133(8):883–885.
   PubMed Web of Science ®Google Scholar
• Swift A. Osteoarthritis 1: Physiology, risk factors and causes of pain. Nurs Times. 2012;108:12–15.
   PubMedGoogle Scholar
• Sun X, Zhen X, Hu X, et al. Osteoarthritis in the middle-aged and elderly in china: Prevalence and influencing factors. Int J Environ Res Public Health. 2019;16.
   PubMed Web of Science ®Google Scholar
• Fang EF, Scheibye-Knudsen M, Jahn HJ, et al. A research agenda for aging in China in the 21st century. Ageing Res Rev. 2015;24:197–205.
   PubMed Web of Science ®Google Scholar
• Chen R, Xu P, Li F, et al. Internal migration and regional differences of population aging: An empirical study of 287 cities in China. Biosci Trends. 2018;12(2):132–141.
   PubMed Web of Science ®Google Scholar
• Tang X, Wang S, Zhan S, et al. The prevalence of symptomatic knee osteoarthritis in china: Results from the china health and retirement longitudinal study. Arthritis Rheumatol. 2016;68(3):648–653.
   PubMed Web of Science ®Google Scholar
• Taruc-Uy RL, Lynch SA. Diagnosis and treatment of osteoarthritis. Prim Care. 2013;40(4):821–836. vii.
   PubMed Web of Science ®Google Scholar
• Rychel JK. Diagnosis and treatment of osteoarthritis. Top Companion Anim Med. 2010;25(1):20–25.
   PubMed Web of Science ®Google Scholar
• Robinson WH, Lepus CM, Wang Q, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580–592.
   PubMed Web of Science ®Google Scholar
• Pearle AD. Warren RF and Rodeo SA. Basic science of articular cartilage and osteoarthritis. Clin Sports Med. 2005;24(1):1–12.
   PubMed Web of Science ®Google Scholar
• Guilak F, Nims RJ, Dicks A. Wu CL and Meulenbelt I. Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol. 2018;71-72:40–50.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Tuan RS. Origin and function of cartilage stem/progenitor cells in osteoarthritis. Nat Rev Rheumatol. 2015;11(4):206–212.
   PubMed Web of Science ®Google Scholar
• Liu S, Yang H, Hu B, et al. Sirt1 regulates apoptosis and extracellular matrix degradation in resveratrol-treated osteoarthritis chondrocytes via the Wnt/β-catenin signaling pathways. Exp Ther Med. 2017;14:5057–5062.
   PubMed Web of Science ®Google Scholar
• Takaishi H, Kimura T, Dalal S, et al. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol. 2008;9(1):47–54.
   PubMed Web of Science ®Google Scholar
• Wang DW, Lin N, Tang YC, et al. Inhibition of P2Y11R ameliorated TNF-alpha-induced degradation of extracellular matrix in human chondrocytic SW1353 cells. Am J Transl Res. 2019;11:2108–2116.
   PubMed Web of Science ®Google Scholar
• Attur M, Yang Q, Shimada K, et al. Elevated expression of periostin in human osteoarthritic cartilage and its potential role in matrix degradation via matrix metalloproteinase-13. Faseb J. 2015;29(10):4107–4121.
   PubMed Web of Science ®Google Scholar
• Hwang HS, Kim HA. Chondrocyte apoptosis in the pathogenesis of osteoarthritis. Int J Mol Sci. 2015;16(11):26035–26054.
   PubMed Web of Science ®Google Scholar
• Sumi C, Hirose N, Yanoshita M, et al. Semaphorin 3A inhibits inflammation in chondrocytes under excessive mechanical stress. Mediators Inflamm. 2018;5703651:2018.
   Google Scholar
• Hayashi M, Nakashima T, Taniguchi M, Kumanogoh A and Takayanagi H, et al. Osteoprotection by semaphorin 3A. Nature. 2012;485(7396):69–74.
   PubMed Web of Science ®Google Scholar
• Romeo PH. Lemarchandel V and Tordjman R. Neuropilin-1 in the immune system. Adv Exp Med Biol. 2002;515:49–54.
   PubMed Web of Science ®Google Scholar
• Song Y, Liu X, Feng X, et al. NRP1 accelerates odontoblast differentiation of dental pulp stem cells through classical wnt/beta-catenin signaling. Cell Reprogram. 2017;19(5):324–330.
   PubMed Web of Science ®Google Scholar
• Zheng L. Luteolin stimulates proliferation and inhibits late differentiation of primary rat calvarial osteoblast induced by high-dose dexamethasone via sema3A /NRP1/Pleixin A1. Curr Pharm Biotechnol. 2020;22:1538-1545.
   Web of Science ®Google Scholar
• Palodetto B, da Silva Santos Duarte A, Rodrigues LM, et al. SEMA3A partially reverses VEGF effects through binding to neuropilin-1. Stem Cell Res. 2017;22:70–78.
   PubMed Web of Science ®Google Scholar
• De Vlaeminck Y, Bonelli S, Awad RM, et al. Targeting neuropilin-1 with nanobodies reduces colorectal carcinoma development. Cancers (Basel). 2020;12.
   Web of Science ®Google Scholar
• Cogan E, Debieve MF, Philipart I. Pepersack T and Abramow M. High plasma levels of atrial natriuretic factor in SIADH. N Engl J Med. 1986;314:1258–1259.
   PubMed Web of Science ®Google Scholar
• Liu G, Wang Y, Zhang M, et al. Long non-coding RNA THRIL promotes LPS-induced inflammatory injury by down-regulating microRNA-125b in ATDC5 cells. Int Immunopharmacol. 2019;66:354–361.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Pereira D, Ramos E, Branco J. Osteoarthritis. Acta Med Port. 2015;28(1):99–106.
   PubMed Web of Science ®Google Scholar
• Lin Y, Xing Q, Qin W, et al. Decreased expression of semaphorin3A/neuropilin-1 signaling axis in apical periodontitis. Biomed Res Int. 2017;8724503:2017.
   Google Scholar
• Rienks M, Carai P, Bitsch N, et al. Sema3A promotes the resolution of cardiac inflammation after myocardial infarction. Basic Res Cardiol. 2017;112: 42.
   Web of Science ®Google Scholar
• Huang B, Zhang Q, Yuan Y, et al. Sema3a inhibits the differentiation of Raw264.7 cells to osteoclasts under 2Gy radiation by reducing inflammation. PLoS One. 2018;13(7):e0200000.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen J, Zhang W, et al. Axon guidance molecule semaphorin3A is a novel tumor suppressor in head and neck squamous cell carcinoma. Oncotarget. 2016;7(5):6048–6062.
   PubMedGoogle Scholar
• Teng Y, Yin Z, Li J, et al. Adenovirus-mediated delivery of Sema3A alleviates rheumatoid arthritis in a serum-transfer induced mouse model. Oncotarget. 2017;8(39):66270–66280.
   PubMedGoogle Scholar
• Sun J, Wei X, Wang Z, et al. Inflammatory milieu cultivated Sema3A signaling promotes chondrocyte apoptosis in knee osteoarthritis. J Cell Biochem. 2018;119(3):2891–2899.
   PubMed Web of Science ®Google Scholar
• Yu H, Pei T, Ren J, et al. Semaphorin 3A enhances osteogenesis of MG63 cells through interaction with Schwann cells in vitro. Mol Med Rep. 2018;17:6084–6092.
   PubMed Web of Science ®Google Scholar
• Okubo M, Kimura T, Fujita Y, et al. Semaphorin 3A is expressed in human osteoarthritic cartilage and antagonizes vascular endothelial growth factor 165-promoted chondrocyte migration: an implication for chondrocyte cloning. Arthritis Rheum. 2011;63(10):3000–3009.
   PubMed Web of Science ®Google Scholar
• Harper J, Gerstenfeld LC, Klagsbrun M. Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem. 2001;81(1):82–92.
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang Q, Wang W, et al. Semaphorin 4A antibody alleviates arsenic-induced hepatotoxicity in mice via inhibition of AKT2/NF-kappaB inflammatory signaling. Toxicol Appl Pharmacol. 2021;410:115364.
   PubMed Web of Science ®Google Scholar